The QualityStocks Daily Wednesday, November 13th, 2019

Today's Top 3 Investment Newsletters

PennyStockProphet (GKIT) +177.78%

QualityStocks (OBMP) +105.00%

SmallCapVoice (VTXB) +68.89%

The QualityStocks Daily Stock List

4Front Ventures Corp. (FFNTF)

Penny Stock Hub, Sweet Dispensary, New Cannabis Ventures, Small Cap Power, Invest Tribune, Investing News, Midas Letter, InvestorsHub, Street Insider, Green Market Report, Market Screener, Freedom Leaf, Investor Ideas, Morningstar, GuruFocus, and Stockhouse reported beforehand on 4Front Ventures Corp. (FFNTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

4Front Ventures Corp. is a cannabis company listed on the OTC Markets Group’s OTCQX. Its team can apply expertise across the value chain. This is from plant genetics to the cannabis retail experience. 4Front has invested considerably to assemble an extensive collection of management skills and hands-on operating expertise to capitalize on the unique growth opportunity offered by the increased legalization of cannabis.

On July 31, 2019, Cannex and 4Front Holdings completed their business combination creating 4Front Ventures. Pure Ratios Holdings is a subsidiary of 4Front Ventures. 4Front Ventures has its head office in Vancouver, British Columbia.

Concerning its operational footprint, 4Front Ventures owns, operates or manages six cultivation and production facilities and 11 retail facilities across eight States. Merger and acquisition discussions are ongoing in the States of California, Nevada, Connecticut, Arizona, and Ohio.

The Company’s capabilities include Extraction & Production – 20-plus brands and greater than 300 SKUs (Stock Keeping Units). Its original cultivation facility in Tumwater, Washington yields 300g/sq. ft. Its new facility in Elma, Washington has demonstrated yields of 400g/ sq. ft. Additionally, 4Front’s capabilities include Packaging & Distribution with logistics and distribution to more than 300 dispensaries in the State of Washington.

Mission is 4Front Ventures' retail division. In Q2 it opened a new dispensary in Rockville, Maryland. It is the third Mission dispensary in Maryland and is the result of a management and licensing relationship with the original license holder. Brightleaf is 4Front's production division. In Q2 it gained control of the entire 94,000 square foot building in Elk Grove Village, Illinois, where the Company's existing production operation is housed. Design work is under way to support a substantial expansion of that operation in response to the adult-use legislation passed in June 2019.

Pure Ratios Holdings has released Pure Ratios Essentials. This is a new line of CBD (cannabidiol) capsules formulated with adaptogenic herbs and mushrooms in four distinct formulations: Move, Calm, Think, and Boost. The Pure Ratios Essentials line is the latest offering from the holistic wellness brand, taking an herbalist’s approach to CBD Hemp. Each capsule is formulated with classical Chinese herbs, mushrooms, and 15 mg of water-soluble CBD Hemp.

Last month, 4Front Ventures announced that, following the closing of its merger with Cannex on July 31, 2019, it has moved quickly to take Cannex's battle-tested operating capabilities, now part of 4Front's production and manufacturing division Brightleaf, and apply them to the Massachusetts market.

Mr. Leo Gontmakher, 4Front Chief Operating Officer, said, "Taking advantage of our pre-merger planning work, we formally took over 4Front's production and processing operations in August. By late September, we had introduced Marmas and Pebbles, two of our most successful edibles brands, to the Massachusetts' medical cannabis market. Most importantly to me, we successfully replicated the low-cost production methods we developed in Washington.”

4Front Ventures Corp. (FFNTF), closed Wednesday's trading session at $0.3163, up 0.412698%, on 153,368 volume with 98 trades. The average volume for the last 3 months is 207,753 and the stock's 52-week low/high is $0.277999997/$2.25.

chart

BioXyTran, Inc. (BIXT)

Born2Invest, Proactive Investors, Investors Hangout, TradingView, Financial Buzz, Nasdaq, Avise Analytics, Wall Street Analyzer, Last10k, Stockwatch, GuruFocus, Biospace, Simply Wall St, Wallet Investor, and Stockopedia reported previously on BioXyTran, Inc. (BIXT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioXyTran, Inc. focuses on developing treatments for stroke and Ischemia. An early stage pharmaceutical company, it centers on the development, manufacture, and commercialization of different therapeutic drugs to address hypoxia in humans. The Company’s lead pharmaceutical drug candidate is BXT-25. BioXyTran is headquartered in Newton, Massachusetts and the Company lists on the OTCQB.

BioXyTran has its BXT-25 and BXT-252. The design of both drugs are to oxygenate ischemic (reduced blood flow) regions of the body and could provide sufferers valuable aid. BXT-25’s co-polymer proprietary chemical structure acts as the chief carrier of oxygen, instead of the Red Blood Cell that are blocked by the clot.

BXT-25 construct considerably lessens methemoglobin formation and nitric oxide scavenging that may contribute to an array of disorders. These disorders include renal failure, vasoconstriction, hypertension, myocardial infarction, and related toxicity issues. In addition, BXT-25’s small size, about 1/5,000th that of a red blood cell, enables it to perfuse constricted, ischemic capillaries that are inaccessible to red blood cells due to clots or other obstructions.

BXT-25, in testing, will undergo evaluation as a resuscitative agent to treat strokes, particularly during the all-critical first hour following a stroke. The product will also undergo evaluation for its efficacy in treating other brain trauma issues.

The design of BioXyTran’s BXT-252 is to treat chronic wounds resulting from ischemia caused by occlusion of capillaries. BXT-252 has the same modality and physical properties as BXT-25. However, its proprietary co-polymer can improve the healing of pressure and arterial ulcers. BXT-25 is founded on a new molecule designed to reverse hypoxia in the brain.

BioXyTran unveiled concept of a new vital sign at Targeting Mitochondria World Congress. The head of BioXyTran’s Scientific Advisory Board, Professor Avraham Mayevsky, presented his abstract titled “Monitoring of Patients’ Mitochondrial Function and Tissue Metabolic Score (TMS) In Critical Care Medicine. A New Standard of Care?” at the Targeting Mitochondria World Congress 2019 in Berlin, Germany on October 29, 2019. The Targeting Mitochondria World Congress is a forum where the pioneers in mitochondrial research can gather and present their ideas and discoveries.

BioXyTran, Inc. (BIXT), closed Wednesday's trading session at $0.60, up 6.9519%, on 5,055 volume with 7 trades. The average volume for the last 3 months is 4,135 and the stock's 52-week low/high is $0.200000002/$1.95000004.

chart

Intrinsyc Technologies Corporation (ISYRF)

TeleTrader, InvestorFile, InvestorX, Portfolio Sharing, PR Newswire, Stockhouse, Ceo.ca, 4-Traders, Virtual-Strategy.com, Stockwatch, Wallet Investor, and MarketBeat reported earlier on Intrinsyc Technologies Corporation (ISYRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Intrinsyc Technologies Corporation is a foremost provider of solutions for the development of embedded and Internet of Things (IoT) products. The Company provides comprehensive product development services, and also the industry’s highest-performance edge computing modules, to enable speedy commercialization of intelligent IoT products. OTCQX-listed, Intrinsyc Technologies is headquartered in Vancouver, British Columbia.

The Company partners with the world’s leading OEMs (original equipment manufacturers) to create award-winning products. These include consumer mobile devices and embedded and IoT applications such as robotics, wearables, automotive, medical, video conferencing, digital signage, industrial and consumer cameras, and many more.

Intrinsyc provides hardware, software, and services that enable next-generation intelligent connected products. Its solutions encompass the entire development life cycle. These solutions help device makers and technology suppliers create differentiated products with quicker time-to-market. Intrinsyc offers a portfolio of embedded computing modules based on Snapdragon™ technology from Qualcomm® Technologies, Inc., and i.MX processors from NXP Semiconductors N.V.

Intrinsyc Technologies announced in May of this year the Open-Q™ 212A SOM and Development Kit. The Open-Q™ 212A SOM is a compact (50mm x 46.5mm) pre-certified, production-ready embedded computing module. It is ideal for cost-sensitive home hub, home automation, and smart audio devices featuring voice control, AI, and wireless connectivity. It is powered by the Qualcomm® Home Hub 300 Platform based on the Qualcomm® APQ8009 System-on-Chip (SoC).

Today, Intrinsyc Technologies announced the receipt of orders during the past week from numerous clients that in aggregate are valued at US$528,000. These orders comprise US$150,000 for hardware and US$378,000 for product development services for clients building robotics, retail point of sale, and smart camera devices. Hardware and services will be delivered in Q4 of Fiscal 2019 ending December 31, 2019.

Tracy Rees, Chief Executive Officer, Intrinsyc Technologies, said, “I’m pleased to announce these orders and the continued interest in Intrinsyc’s edge AI computing modules and product development services for creation of intelligent IoT products.”

Intrinsyc Technologies Corporation (ISYRF), closed Wednesday's trading session at $1.1999, up 4.3391%, on 277,575 volume with 120 trades. The average volume for the last 3 months is 22,429 and the stock's 52-week low/high is $0.80489999/$1.25997996.

chart

MJardin Group, Inc. (MJARF)

Street Register, CannabisMarketCap, Trading View, NIC Investors, OTC Markets, New Cannabis Ventures, Stockhouse, GuruFocus, Midas Letter, Stockwatch, and MarketBeat reported beforehand on MJardin Group, Inc. (MJARF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQX-listed, MJardin Group, Inc. is a leader in premium cannabis production. The Company is a cannabis management platform with comprehensive experience in cultivation, processing, distribution and retail. MJardin has more than 10 years of commercial growing experience in North America. Established in 2014, MJardin Group is headquartered in Denver, Colorado. The Company also has an office in Toronto, Ontario.

At present, MJardin Group owns, manages or advises on a portfolio of 32 cannabis operations. The Company has refined cultivation methodologies, developed state-of-the-art facilities and implemented vertical integration for and on behalf of license owners. It has designed 105 cannabis facilities across 13 U.S. States, 3 Canadian Provinces and Australia. Since 2014, it has produced 110,000 kilograms of cannabis.

MJardin has entered into a definitive agreement to acquire Carson City Agency Solutions, dba Cannabella, an operator of an extraction facility and producer of edibles and topicals in Carson City, Nevada. This Transaction will add extraction capabilities to MJardin’s present cultivation operations in Nevada, allowing it to use a portion of its cultivation output for extracts towards edibles, topicals and other potential product lines.

MJardin Group has completed construction of “GRO”. This an indoor cannabis cultivation facility situated in Dunnville, Ontario. The Company has submitted its Evidence of Readiness package to Health Canada. The facility is a joint-venture (JV) between MJardin Group (75 percent) and Grand River Organics (25 percent).

The estimation is that the 11,000 square foot facility will produce 1,260 kg of premium flower and 454 kg of trim, for a total of 1,714 kg of product annually. “GRO” is MJardin Group’s third Canadian cannabis cultivation facility to complete construction and second in Ontario as it joins “WILL”, a 32,800 square foot cultivation facility in Brampton that was awarded its sales license in December of 2018.

MJardin Group also has its Warman Road project in Winnipeg, Manitoba. This is a hybrid facility encompassing indoor and greenhouse production along with full EU GMP certified extraction, processing and packaging capabilities.

Last month, MJardin Group announced that it agreed to issue 741,765 common shares in the capital of MJardin to the seller of Carson City Agency Solutions LLC (which does business under the trade name Cannabella), as a non-refundable pre-payment of the $4.5 million USD purchase price, of which $500,000 USD was paid as cash consideration at the time of execution for the earlier announced acquisition of Cannabella. Cannabella’s products are already in roughly 50 of the 68 retail dispensaries in Nevada.

Yesterday, MJardin Group announced that it entered into a partnership with Robes, Inc., a luxury cannabis brand house focused on bringing exotic and rare strains to Canadian consumers. With this partnership agreement, MJardin will cultivate specific innovative strains as selected by Robes, for the Canadian market. Robes owns brands such as BLLRDR and Robes Cannabis. Robes also has an extensive catalogue of market-leading cannabis genetics including the Afghani Bullrider.

MJardin Group, Inc. (MJARF), closed Wednesday's trading session at $0.44337, up 0.765909%, on 2,719 volume with 12 trades. The average volume for the last 3 months is 37,193 and the stock's 52-week low/high is $0.232099995/$6.68370008.

chart

Pacific Booker Minerals, Inc. (PBMLF)

Zacks, Geology for Investors, OTC Markets, Market Screener, InvestorX, Last10k, Stockhouse, TMXmoney, 4-Traders, TradingView, Wallet Investor, Stockwatch, Morningstar, Barchart, GuruFocus, and Dividend Investor reported earlier on Pacific Booker Minerals, Inc. (PBMLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pacific Booker Minerals, Inc. (PBM) owns the Morrison property in Central British Columbia, 35 km north of the Village of Granisle. The Company is in the advanced stage of development of the Morrison porphyry copper/gold/molybdenum deposit. PBM has completed a Feasibility Study (FS) and 43-101 compliant Technical Report. It is proposing an open-pit mining and milling operation for the production of copper/gold/molybdenum concentrate from the Morrison deposit. The Company purchased the Morrison property in April of 2004. PBM is based in Vancouver, British Columbia.

The total mineable reserve (according to the FS), classified as proven and probable, at Net Smelter Return (NSR) cut-off-value of $CDN5.60/t, is 224.25Mt with an average grade of 0.330% Copper, 0.163g/t Gold and 0.004% Molybdenum. FS highlights also include recovered metal of 1.37 billion lbs Copper, 658,090 oz Gold, and 10.047 million lbs Molybdenum. The Mine life is 21 years.

PBM announced in July 2019 that the Chief Gold Commissioner issued a mining lease in the area known as the Morrison mine project and consisting of mineral claims 625123, 625143, and 625183, covering about 1,090 ha, for an initial term of one year and not the maximum 30-year term requested by PBM in its August 28, 2009 application. The three mineral claims are situated along the shore of Morrison Lake, roughly 65 kilometers northeast of Smithers, British Columbia.

The Morrison deposit has the advantage of existing regional infrastructure to service the region. This includes a deep-sea shipping terminal at the port of Stewart, B.C., a road network, nearby hydro-electric power (20 km from the project site), two existing nearby forestry camps for preproduction use, and a full service town (the Village of Granisle) within daily commuting distance from the project site.

The Feasibility Study for the Morrison property was completed by Wardrop Engineering Ltd., a Tetra Tech Company, with technical support of a team of other consultants. The study describes the scope, design features and financial viability of a conventional open pit mine with a 30,000 tonnes per day mill.

Pacific Booker Minerals, Inc. (PBMLF), closed Wednesday's trading session at $1.83, even for the day. The average volume for the last 3 months is 506 and the stock's 52-week low/high is $0.550000011/$3.0999999.

chart

Till Capital Ltd. (TILCF)

Zacks, All Stocks Today, TipRanks, MacroTrends, Investors Observer, Investing.com, MarketWatch, Market Screener, TradingView, TMXmoney, Stockhouse, Wallet Investor, Morningstar, Dividend Investor, and Nasdaq reported previously on Till Capital Ltd. (TILCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A Bermuda-domiciled company, Till Capital Ltd. owns Omega General Insurance Company. Omega is a Canadian insurance company offering unique and customized insurance industry solutions, including fronting and run-off services for insurers/reinsurers, within the Canadian marketplace. In addition, Omega Insurance Holdings, Inc. operates Focus Group, Inc. Focus is a consulting and project management company servicing the local and international needs of its Property Casualty Insurance clients. Incorporated in 2012, Till Capital has its corporate headquarters in Hamilton, Bermuda.

Managed by Till Management Company, Mr. William A. Lupien, the Chief Investment Officer, oversees and directs the investment portfolio of Till Capital. Longer term equity investment is augmented by short term trading in an assortment of financial instruments.

Overall, by way of its subsidiaries, Till Capital engages in the insurance and reinsurance business in Canada, Bermuda, and the United States. It provides assumption reinsurance to insurance companies that want to exit the Canadian market; and to insurance companies that want to transfer their remaining claim liabilities on particular books of business.

Furthermore, it acts as the main insurer and direct writer for insurance companies seeking Canadian business, but lacking the appropriate Canadian insurance licenses; and ongoing and one-time consulting services in the areas of taxation, risk management, mergers and acquisitions, expert witness testimony, and claim reviews.

Omega General’s chief source of revenue is from incoming Canadian branch offices in “run off.” Omega General earns a premium on such portfolio transfer transactions above the transferring company’s claim liabilities. The second area of Omega General’s underwriting areas is a direct insurance premium business. Omega General usually purchases reinsurance for its portfolio transfer and direct insurance premium businesses.

Focus Group has been providing management and consulting services to the insurance industry for greater than 25 years. Focus has considerable experience and expertise in managing the operations of foreign insurance companies wishing to operate in Canada without establishing a fully-staffed Canadian operation. Focus provides management services to Omega General and a complete range of consulting and management services to other clients.

Till Capital Ltd. (TILCF), closed Wednesday's trading session at $1.48, up 45.098%, on 1,310 volume with 6 trades. The average volume for the last 3 months is 778 and the stock's 52-week low/high is $1.01999998/$2.1400001.

chart

Tombstone Exploration Corporation (TMBXF)

OTC Markets, Stock Day Media, Investing News, Dividend Investor, Wallet Investor, TipRanks, Stockhouse, Investors Hangout, MarketWatch, 4-Traders, GuruFocus, GlobeNewswire, TradingView, Morningstar, Dividend.com, Last10k, Investing.com, and InvestorsHub reported earlier on Tombstone Exploration Corporation (TMBXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tombstone Exploration Corporation is a gold, silver and copper exploration company listed on the OTC Markets Group’s OTCQB. Its goal is to maximize shareholder value via focused exploration, testing and development of high-quality mineral targets in the prolific mineral producing areas in the Southwest United States. The Company’s projects include the Bonanza Project, the Tombstone Project, the Stardust Project, and the Bahamas Lime Rock Project. Tombstone Exploration is based in Scottsdale, Arizona.

The Bonanza Project is in Salome, Arizona. Ownership is 40 percent Tombstone, 60 percent Goldrock Resources, Inc. The minerals are Gold, Silver and Copper and the property size is 2,656 acres.

The Tombstone Project is in Tombstone, Cochise County, Arizona. Ownership is 100 percent Tombstone Exploration. The minerals are Gold, Silver and Copper and the property size is 600 acres.

The Stardust Project is in Yuma County, Arizona (Eagletail Mining District). Ownership is 100 percent Tombstone Exploration. The minerals are Gold, Silver, Copper and Molybdenum and the property size is 400 acres.

The Bahamas Lime Rock Project is in Freeport, Grand Bahama Island. Regarding ownership, 100 percent ownership is by Bahamas Aggregates. Tombstone Exploration receives a monetary portion of every ton produced on the property.

This past September, Tombstone Exploration provided an update on its operations and outlook. The Company has been working diligently to get the Bonanza Project into production. The permitting process for the Bonanza Project is close to completion. Tombstone is expecting completion and approval of all the required permits during November/December 2019. It will immediately begin the construction phase upon receipt.

Tombstone Exploration completed the filings and payments for all of its Bureau of Land Management (BLM) mining claims for the Stardust Project located in the Eagletail Mining District of Yuma County, Arizona on August 29, 2019. The Company is continuing its exploration plan on the Stardust Property that is 100 percent owned by Tombstone Exploration.

Tombstone Exploration Corporation (TMBXF), closed Wednesday's trading session at $1.60, up 5.9603%, on 5,020 volume with 12 trades. The average volume for the last 3 months is 1,787 and the stock's 52-week low/high is $0.119999997/$3.79999995.

chart

TearLab Corporation (TEAR)

Zacks, MacroTrends, TipRanks, Simply Wall St, Nasdaq, Market Screener, GlobeNewswire, Investing.com, Morningstar, BioSpace, and TMXmoney reported earlier on TearLab Corporation (TEAR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, TearLab Corporation develops and markets lab-on-a-chip technologies. These technologies enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The Company’s mission is to pioneer the future of tear film diagnostics to elevate patient care. TearLab is headquartered in Escondido, California.

The TearLab Osmolarity Test is for diagnosing Dry Eye Disease. It is the first assay developed for the award-winning TearLab Osmolarity System. The TearLab Osmolarity System is a proprietary in vitro diagnostic tear testing platform. It measures tear film osmolarity for the diagnosis of dry eye disease. It also enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care.

The Company’s TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab pen, a hand-held device that interfaces with the TearLab disposable; and TearLab reader, a small desktop unit that allows for the docking of the TearLab pen, and also provides a quantitative reading for the operator.

Last month, TearLab reported its consolidated financial results for Q2 ended June 30, 2019. The Company grew quarterly Revenue sequentially to $5.9 million, a $0.2 million increase versus the first quarter of 2019. TearLab had a Cash position of $9.2 million as of June 30, 2019, an increase from $8.9 million as of March 31, 2019 and $8.5 million as of December 31, 2018. It expanded the U.S. active device base to 4,811 TearLab Osmolarity Systems.

TearLab’s reported Net Loss for the 2019 second quarter was roughly $1.2 million, or ($0.10) basic loss per share, versus a reported Net Loss of roughly $0.7 million, or ($0.06) basic loss per share in Q2 of 2018.

Seph Jensen, TearLab’s Chief Executive Officer, said, “We were pleased to deliver revenue growth over prior quarter, capitalizing on the current market momentum for osmolarity and growing our customer base. In the second quarter of 2019, we continued to strengthen our cash position and work diligently on the resubmission of our 510(k) application to secure FDA clearance of our next-generation TearLab Discovery™ System.”

TearLab Corporation (TEAR), closed Wednesday's trading session at $0.075, up 77.305%, on 31,690 volume with 10 trades. The average volume for the last 3 months is 29,740 and the stock's 52-week low/high is $0.029999999/$0.150000005.

chart

All For One Media Corp. (AFOM)

OTC Markets, MarketWatch, Global Energy Media, Central Charts, Simply Wall St, Pink Investing, Stock Digest, Penny Stock Tweets, Street Register, Stockhouse, Financial Content, Emerging Growth, The Street, Market Exclusive, InvestorsHub, Capital Network, Proactive Investors, and Barchart reported earlier on All For One Media Corp. (AFOM), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

All For One Media Corp. is a tween marketing company listed on the OTC Markets’ OTCQB.  Named “Generation I” for "Internet," this generation's tweens represent the first demographic to have had only known life with the Internet and social media. Essentially, All For One Media is a marketing brand changing the mindset of tweens that bullying is unacceptable. All For One Media has its head office in Mount Kisco, New York.

The Company is working to make the transition from a development stage corporation creating and acquiring media assets to a content provider launching many initiatives marketed to its core tween demographic. Its goal is to capitalize on a broad variety of potential revenue streams.

All For One Media, through entertainment, is working to deliver a message that will resonate with kids to impact the epidemic of bullying and cyber-bullying. In addition, it is working to help individuals who have been affected by bullying to deal with it in a positive and constructive manner.  

All For One Media has produced Drama Drama (f/k/a "Crazy For the Boys"). Drama Drama is a full length coming of age musical dramedy. It features Groovy Tuesday music and choreography. This film tells the story of five high school girls from five very different cliques who must work together to run their school’s anti-bullying organization. The film features original pop songs pertaining to peer pressure, unrequited love, and teen angst. The expectation is that Drama Drama will generate revenues from numerous sources.

The Company has completed production of Drama Drama. It has started to screen the movie for buyers. Moreover, it engaged William Morris/Endeavor Content (WME) as the exclusive sales agent for the film. WME represents artists across all media platforms, particularly movies, television, music, theatre, digital and publishing.

All for One Media is making plans to commence group activities for the launch of the band "Drama Drama" concurrent to the release of the movie. The release of a full-length film used to promote the launch of a pop group is an industry first. The Company has also started negotiations with a number of major record labels for distribution of the film soundtrack.

All For One Media Corp. (AFOM), closed Wednesday's trading session at $0.0024, up 60.00%, on 42,283,612 volume with 285 trades. The average volume for the last 3 months is 575,395 and the stock's 52-week low/high is $0.001049999/$0.104999996.

chart

Rhino Resource Partners LP (RHNO)

Zacks, MarketWatch, Mining Connection, GlobeNewswire, Annual Reports, TopPennyStockMovers, Marketbeat, Simply Wall St, 4-Traders, Dividend Channel, Wall Street Mover, and PCG Advisory reported earlier on Rhino Resource Partners LP (RHNO), and today we report on the Company, here at the QualityStocks Daily Newsletter.   

OTCQB-listed, Rhino Resource Partners LP is a diversified energy limited partnership. It concentrates on coal and energy related assets and activities. This includes energy infrastructure investments. Rhino is a diversified energy MLP (Master Limited Partnership). It produces coal in numerous basins in the U.S. Rhino Resource Partners has its head office in Lexington, Kentucky.

The Company, through acquisitions and other coal lease transactions, has substantially increased its proven and probable coal reserves and non-reserve coal deposits. Furthermore, Rhino has successfully increased its coal production by way of internal development projects.

   The Company produces metallurgical and steam coal in an array of basins across the U.S. as well as leases coal. Rhino’s strategy is to acquire coal reserves and properties with relatively long lives and that could undergo development with low risk at a reasonable cost.

Rhino produces steam coal used to produce electricity and metallurgical coal used in the steel-making process. In addition, the Company manages and leases coal properties and collects royalties from such management and leasing activities. Rhino also has oil and gas investments in the Cana Woodford region that provides added cash flows to its business. 

  In Central Appalachia, approximately 72 percent of its full-year 2019 thermal and met coal production has been contracted at increased prices in comparison to 2018. Rhino’s Pennyrile, Castle Valley and Hopedale operations are considerably sold out for 2019 at prices that are above the Company’s 2018 levels. Moreover, Rhino has executed long-term contracts with different utility customers for thermal coal for 2020 at Pennyrile and Castle Valley.

This week, Rhino Resource Partners announced its financial and operating results for the quarter ended December 31, 2018. For the quarter, the Partnership reported a Net Loss of $5.6 million and Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $6.3 million, versus a Net Loss of $18.7 million and Adjusted EBITDA of $6.7 million in Q4 of 2017.

Diluted Net Loss Per Common Unit was $0.49 for the quarter versus Diluted Net Loss Per Common Unit of $1.45 for Q4 of 2017. Total Revenues for the quarter were $64.7 million, with coal sales producing $63.9 million of the total, versus Total Revenues of $55.8 million and coal revenues of $55.4 million in the fourth quarter of 2017.

Rhino Resource Partners LP (RHNO), closed Wednesday's trading session at $0.50, up 61.2903%, on 2,410 volume with 4 trades. The average volume for the last 3 months is 1,532 and the stock's 52-week low/high is $0.085500001/$1.50.

chart

Nippon Dragon Resources, Inc. (RCCMF)

OTC Markets Group, InvestorsHub, MarketWatch, Investor Place, Stock Gumshoe, Zacks, Dividend Investor, Morningstar, Talk Markets, Streetwise Reports, 4-Traders, Wallet Investor, GuruFoucs, YCharts, and Stockhouse reported previously on Nippon Dragon Resources, Inc. (RCCMF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Nippon Dragon Resources, Inc. is a hybrid mining & technology enterprise listed on the OTC Markets. The Company has high potential and advanced stage mining assets combined with an innovative and exclusive green mining method. Nippon is active in the exploration and development of gold resources in the Province of Quebec. Nippon’s flagship gold property is Rocmec 1. Nippon Dragon Resources is headquartered in Brossard, Quebec.

The Company has its Thermal Fragmentation mining method. This mining method uses heat to 'spall' high-grade veins. This considerably lessens the use of explosives. The method only extracts the mineralized ore with minimal dilution. The extraction process allows thermal fragmentation with an accuracy of 2 cm to quickly extract any type of hard rock up to 110 cm wide. The thermal unit can be set up to extract a specific corridor. Thermal Fragmentation could be used as a stand-alone method or as a first-rate complement to any conventional hard rock mining operation.

In June of last year, Nippon Dragon Resources announced that following the sale of a Thermal Fragmentation Unit to its client, Metalfer Mining D.O.O, the Unit was shipped, received, inspected by border authorities and released to the client. Nippon’s technical team performed its customary four week orientation, training, and implementation programme of its thermal fragmentation mining method at Metalfer’s mining site in the Majdan Mountain district of Serbia.

Nippon Dragon Resources has a strategic partnership agreement with Val d’Or Resources (VOR). This partnership agreement will enhance Nippon Dragon’s position as an industry leader with its exclusive and patented Thermal Fragmentation technology. Through the creation of a new entity, Rocmec Gold, Inc., the new partnership is anticipated to substantially expand Nippon Dragon’s reach within Canada and other important markets.

Nippon’s flagship Rocmec 1 is a fully permitted project in Quebec. The project includes a 100-meter deep, two-compartment shaft, and an 844 meters decline, allowing access to four levels (50, 90, 110 and 130 meters).

Additionally, Nippon has its Denain Project. This project covers two contiguous mining properties (Venpar and Vauquelin) totaling 24 mining titles. The Denain Project is about 60 km east of Val d'Or, Quebec. At the end of August 2018, Nippon Dragon Resources announced that it signed a joint venture (JV) agreement with a group of private investors to develop its Denain gold property.

In addition, Nippon has its Courville-Maruska exploration property in Courville Township, roughly 32 kilometers’ northeast of Val-d'Or, Quebec. The property consists of 20 mining claims covering an area of around 800 hectares. The property is on a gold-bearing quartz vein system.

Nippon Dragon Resources, Inc. (RCCMF), closed Wednesday's trading session at $0.032, up 60.00%, on 127,806 volume with 6 trades. The average volume for the last 3 months is 1,532 and the stock's 52-week low/high is $0.002/$0.032000001.

chart

IronClad Encryption Corporation (IRNC)

4-Traders, PennyStockHub, The Street, Simply Wall St, MarketWatch, InvestorsHub, OTC Markets, YCharts, Barchart, Investors Hangout, Stock News Now and TradingView reported earlier on IronClad Encryption Corporation (IRNC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

IronClad Encryption Corporation is a next-generation cyber defense company headquartered in Houston, Texas. Its strategic and tactical data protection solutions strengthen existing encryption methods. The Company’s technology can provide continuous authentication of encrypted data transmitted, creating much stronger defenses to most hacker attacks. IronClad Encryption lists on the OTC Markets’ OTCQB.

IronClad Encryption-powered solutions use the Company’s patented Dynamic Encryption and Perpetual Authentication technologies to make all known key-based encryption technologies almost impossible to compromise. Dynamic Encryption Technology eliminates vulnerabilities caused by exposure of any single encryption key through continually changing encryption keys and keeping the keys synchronized in a fault-tolerant way.

Dynamic Encryption technology eliminates the single point of failure problem inherent in single-key encryption techniques. IronClad’s key management system continuously produces synchronous keys between the sender and receiver. Each key is assigned to a small amount of data. Therefore, if a hacker were to access one of hundreds of millions of keys, the amount of data he would obtain would be almost useless.

IronClad Encryption has a partnership with Black Pearl Engineering Management, Inc. to co-develop ultra-secure products based on IronClad’s patented ultra-secure cybersecurity algorithms and methodologies. The joint venture (JV) operates under the name "Black ICE". It is initially focusing on network gateway products. BlackICE Barrier is the first product in a family of BlackICE products. BlackICE Barrier is specifically targeted at enterprises and industrial use cases where data and control systems require the highest level of security.

IronClad Encryption offers its ICEMicro. This is the world’s first context-free and natively-secure container. It enables all developers to take ownership of application data security. Employing ICEMicro, any developer can secure communication between containers across varied scheduling and orchestration platforms, IaaS services, transport-layer security protocols, and on-premises or hybrid environments utilizing Docker-compatible hypervisors.

Recently, IronClad Encryption announced that it received notice from the United States Patent and Trademark Office (USPTO) that six of its patents were allowed. The titles of the IronClad patents that have been provided a Notice of Allowance include: Securitization of Temporal Digital Communications with Authentication and Validation of User and Access Devices; User-Wearable Secured Devices Provided Assuring Authentication and Validation of Data Storage and Transmission; and Devices that Utilize Random Tokens Which Direct Dynamic Random Access.

Titles also include: Devices for Transmitting and Communicating Randomized Encrypted Data Utilizing Sub-Channels; Executable Coded Cipher Keys; and Combined Hidden Dynamic Random-Access Devices Utilizing Selectable Keys and Key Locators for Communicating Randomized Data together with Sub-Channels and Coded Encryption Keys.

IronClad Encryption Corporation (IRNC), closed Wednesday's trading session at $0.0002, up 100.00%, on 150,950,972 volume with 61 trades. The average volume for the last 3 months is 29,514,479 and the stock's 52-week low/high is $0.00009/$0.310000002.

chart

HighCom Global Security, Inc. (HCGS)

NetworkNewswire.com, Stockopedia, Marketwired, InvestorsHub, and 4-Traders reported on HighCom Global Security, Inc. (HCGS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, HighCom Global Security, Inc. is a foremost provider of equipment and services for the security and defense industries. The Company is establishing a wide-ranging portfolio of security businesses. It acquires, manages, and builds industry leading businesses that provide specialized, mission-critical solutions, which address the needs of its customers.

The Company previously went by the name BlastGard International, Inc. It changed its name to HighCom Global Security, Inc. in August of 2014. HighCom Global Security has its head office in Columbus, Ohio.

The Company’s HighCom Armor division provides high performance and affordable body armor, personal protective equipment, as well as armor systems and related accessories. Its ballistic solutions have undergone deployment to hundreds of thousands of operators globally. This includes the U.S. armed forces, allied forces, federal government agencies, plus law enforcement and corrections, and other security personnel, domestically and internationally.

HighCom Armor Solutions, Inc. designs, develops, tests, manufacturers, and distributes body armor and personal protective equipment. This includes greater than two dozen NIJ compliant hard and soft armor products.

HighCom Global Security’s BlastGard Technologies division has patented BlastWrap® technology. This technology acts as a “virtual tent” to effectively lessen blast effects and suppress post-blast fires.

The innovative BlastWrap® technology works by triggering physical and chemical processes to dissipate blast energy. As a result, this reduces the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, considerably decreased energy is transmitted at a slower, more sustainable level.

BlastWrap® does not dispense chemical extinguishants. It uses neither alarms, sensors, nor an activation system. In addition, BlastWrap® is nontoxic and ecologically friendly.

Last month, HighCom Global Security announced that Mr. Craig Campbell, an Executive Officer and Director of the Company, submitted his resignation to the Board of Directors, effective Tuesday, January 16, 2018. Francis Michaud, who currently serves as Chief Financial Officer of the Company, was elected to the Board to fill the vacancy left by Mr. Campbell and was also appointed to serve as Chief Executive Officer (CEO).

HighCom Global Security, Inc. (HCGS), closed Wednesday's trading session at $0.00797, up 56.2745%, on 22,400 volume with 3 trades. The average volume for the last 3 months is 29,514,479 and the stock's 52-week low/high is $0.002649999/$0.012699999.

chart

OncBioMune Pharmaceuticals, Inc. (OBMP)

MissionIR, Otcstockexchange, Whisper from Wall Street, and Journal Transcript reported on OncBioMune Pharmaceuticals, Inc. (OBMP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OncBioMune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development of targeted cancer therapies, a proprietary cancer vaccine technology, and commercialization of a portfolio of products globally. OncBioMune has a proprietary Vaccine Technology designed to stimulate the immune system to attack its own cancer while not hurting the patient. The Company incorporates scientifically proven and clinically validated treatments for cancer. OncBioMune Pharmaceuticals is based in Baton Rouge, Louisiana. The Company lists on the OTCQB.

OncBioMune Pharmaceuticals’ lead product is ProscaVax™. This is its novel cancer vaccine for prostate cancer. ProscaVax is now undergoing evaluation in a Phase 1 clinical study at the University of California San Diego Moores Cancer Center and Veterans Hospital in La Jolla, California, funded in part by the Department of Defense US Navy Cancer Vaccine Program.

ProscaVax consists of a combination of prostate cancer associated PSA with the biological adjuvants interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF).

Moreover, the Company has a portfolio of targeted therapies. Some of these are biosimilars to blockbuster drugs. OncBioMune has developed the therapeutic cancer vaccine for prostate cancer patients using similar techniques developed for breast cancer patients.

OncBioMune states that it is tested and laboratory proven and that it could become the standard of care for prostate cancer treatment. OncBioMune Pharmaceuticals uses patented technology developed and or acquired by the Company.

In September 2017, OncBioMune Pharmaceuticals announced that it successfully attained development milestones in formulation and stability with tretinoin, also known as all-trans retinoic acid (ATRA). This is an oral drug for the treatment of Acute Promyelocytic Leukemia (APL). The Company owns the commercialization rights for tretinoin throughout Mexico, Central America, and Latin America.

Earlier this month, OncBioMune Pharmaceuticals provided the latest data from its successfully completed Phase 1 trial of ProscaVax for prostate cancer, suggesting a durable response 31 weeks post-therapy. In the Phase 1 clinical trial, hormone-naïve and hormone-independent recurrent prostate cancer patients with rising prostate specific antigen (PSA) were treated with six intradermal injections of ProscaVax.

Dr. Jonathan Head, Chief Executive Officer at OncBioMune Pharmaceuticals, said, “I’m very excited about this data, as I can’t think of another study to have 75 percent of recurrent prostate cancer patients with rising PSA experience stable disease nearly eight months after therapy ended. .. Now, we have to expand the therapeutic range and increase the number of patients enrolled in mid-stage research, but the data to date certainly is encouraging to provide a safe and effective treatments for the millions of men battling prostate cancer today.”

OncBioMune Pharmaceuticals, Inc. (OBMP), closed Wednesday's trading session at $0.205, up 105.00%, on 33,730 volume with 13 trades. The average volume for the last 3 months is 7,475 and the stock's 52-week low/high is $0.100000001/$26.25.

chart

The QualityStocks Company Corner

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, this morning announced that it has been awarded a phase 2 rapid test and evaluation (“RTE”) contract by a leading global energy technology company for the pilot deployment of PrintRite3D(R) in-process quality assurance software following successful completion of the phase 1 RTE program. To view the full press release, visit http://nnw.fm/87Dot.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Wednesday's trading session at $0.67, up 3.0769%, on 126,460 volume with 373 trades. The average volume for the last 3 months is 176,235 and the stock's 52-week low/high is $0.451099991/$2.46000003.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com’s (OTCQB: CIIX) China Division was featured in a video published by The Wall Street Journal today, which highlighted Chinese entrepreneurs and opportunities to cash in as products made with cannabidiol (“CBD”) take off in the U.S. The accompanying article, written by Stephanie Yang and Clément Bürge, highlighted the fact that, while marijuana is still seen as a dangerous narcotic in China, Chinese entrepreneurs “are navigating the highly-sensitive industry as they try to turn their country into a CBD superpower.” To view the full press release, visit http://cnw.fm/N3a3i.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Wednesday's trading session at $0.269, up 14.4681%, on 115,617 volume with 44 trades. The average volume for the last 3 months is 43,215 and the stock's 52-week low/high is $0.165000006/$0.660000026.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Leading technology and acquisition company SinglePoint (OTCQB: SING)today announced its financial results for the third quarter ended September 30, 2019. According to the update, the company achieved revenues of $1,050,374 for the three months ended September 30, 2019, a 176% increase over the same period in 2018. Per the update, the initial response to the company’s Pure American Hemp Cigarette has been overwhelming, while Direct Solar, SinglePoint’s most recent acquisition, continues to exceed revenue targets and has been pivotal to the company’s financial growth. To view the full press release, visit http://cnw.fm/fW1Qn

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Wednesday's trading session at $0.0114, up 3.6364%, on 3,873,291 volume with 113 trades. The average volume for the last 3 months is 2,633,579 and the stock's 52-week low/high is $0.009999999/$0.028799999.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG)has gained momentum in its record sales by employing its Blue Ocean Strategy, a unique and successful method of selling its proprietary product line through its Elepreneur independent distributors. Since the company’s own line of health and wellness products was introduced in December 2017, SHRG has reported cumulative sales of greater than $129 million. For Q1 2019, the three months ending July 31, Sharing Services reached revenues of $35.4 million, more than double that of the comparable period in 2018 (http://nnw.fm/6wTn8).  

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed Wednesday's trading session at $0.127, up 5.8333%, on 12,200 volume with 4 trades. The average volume for the last 3 months is 35,748 and the stock's 52-week low/high is $0.090000003/$0.3944.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in a publication from CannabisNewsWire, examining how the Yale School of Medicine and CT Pharmaceuticals Solutions Inc. have teamed up to conduct a study on the impact of medical marijuana on stress and mental health. On Friday, Yale and CT Pharmaceuticals announced that they would be conducting a phase-one study on the effects of a variety of cannabis strains with medicinal qualities for alleviating pain and stress.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Wednesday's trading session at $1.08, up 2.8571%, on 301,952 volume with 401 trades. The average volume for the last 3 months is 216,379 and the stock's 52-week low/high is $0.843599975/$5.20499992.

Recent News

chart

InsuraGuest Inc.

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Inc..

InsuraGuest, through its proprietary InsurTech software platform, empowers both hotels and vacation rental properties a way to provide protection for their guests. An article discussing the company reads, “People who plan to travel overseas or go on vacation are often encouraged to buy travel insurance to provide some protection from illness or accidents that may occur while traveling or visiting another country, but these policies may exclude or may be limited for accidents that happen at a vacation rental property or hotel. To view the full article, visit http://nnw.fm/0hfAQ

InsuraGuest Inc. is a SaaS (Software-as-a-Service) company utilizing its proprietary flagship InsurTech software platform to provide specialized insurance products to end users in the business-to-business (B2B) and business-to-consumer (B2C) markets. The company’s first focus is on the B2B hotels and vacation rentals sectors, where its API integrates with the clients’ property management systems to offer guests a specialized guest protection policy. The platform and policy combination “InsurTech” product helps transfer the exposure to liability away from the client/property while guests benefit from potential accident and loss coverage during their stay.

InsuraGuest’s platform is currently capable of integrating with approximately 70 different hotel and vacation rental property management systems, giving it access to roughly 40,000 properties worldwide.

The company continues to pursue expansion opportunities and recently signed a Letter of Intent with a master general agent in the United Kingdom and Europe to distribute its platform and products to hotel and vacation rental markets in those regions, as well as plans to expand to Asia in 2020.

Protecting Guests, Enhancing Customer Experience

InsuraGuest is the first line of defense for both the property and the guest.

InsuraGuest is purchased by the hotel or vacation rental “property,” which offers the policy to each registered guest and its occupants for an additional fee. The specialized policy affords coverage for theft of personal property while in the hotel, as well as accidental medical expense and accidental death and dismemberment, up to the policy limits of $2,500 to $50,000.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United State alone, where there are approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s demographics combined will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Specialized Guest Protection Policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Business Highlights

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a BS undergraduate degree in Consumer Studies with an emphasis in Architecture as an undergraduate at the University of Utah. He subsequently earned his Master’s in Business Administration. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends.

Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Christopher J. Panos Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018. He also has served as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.


Recent News

chart

Xalles Holdings Inc. (OTC: XALL)

The QualityStocks Daily Newsletter would like to spotlight Xalles Holdings Inc. (OTC: XALL).

The potential benefits of riding out crypto volatility were again on display in late October as Bitcoin suddenly surged over $500 in just five minutes, joined in the ride by other top-20 coins that simultaneously posted gains, with some of them seeing double-digit price increases (http://ccw.fm/zpwE3). A larger indication of alt-coins’ persistence emerged in trends developing at a national level in South America and Asia. Fintech holding company Xalles Holdings Inc. (OTC: XALL)is an experienced payment systems and solutions builder that has become a dedicated believer in the cryptocurrency market, celebrating the upsides of crypto’s free trade system despite risks inherent in Bitcoin’s volatility such as when the alt-coin standard bearer experienced a series of significant drops after rallying to August highs.

Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.

Operations

The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.

Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.

Subsidiaries
All current subsidiaries are wholly owned

  • Xalles Holdings
    Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
  • Xalles Capital
    Management support of investment consortiums, direct investment into funds or projects, and management of investments
  • Xalles Limited
    Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
  • Xalles Technology
    Technical development of the X2X blockchain systems
  • Xalles Financial Services
    Consumer and small business financial service offerings
  • Co-Owners Rewards
    Stock-based rewards system for payments cards and financial services
  • Amazing Living Enterprises
    Affiliate program and e-commerce platform for enhancing financial lives
  • Global Savings Network
    Not-for-profit fundraising system with consumer discounts at local merchants

X2X Solutions

Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.

Advancements in 2019

  • Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
  • Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
  • Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.

“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”

– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)

Xalles Holdings Inc. (OTC: XALL), closed Wednesday's trading session at $0.003, even for the day, on 1,919,980 volume with 29 trades. The average volume for the last 3 months is 1,673,062 and the stock's 52-week low/high is $0.0013/$0.021029999.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings Inc. (OTC: MCTC) was featured today in a publication from CannabisNewsWire, examining why MCTC is “One to Watch.”

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Wednesday's trading session at $1.08, off by 1.8182%, on 1,640 volume with 12 trades. The average volume for the last 3 months is 9,444 and the stock's 52-week low/high is $0.075000002/$3.00.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC).

HTC Extraction Systems (TSX.V: HTC) was featured today in a publication from CBDWire, examining how, for the past couple of years, interest in cannabidol (CBD) has been gaining traction in Europe and the U.S., mostly caused by the cannabis extract’s abilities as a versatile natural medication. Although there has been little conclusive scientific research on the efficacy and side effects of CBD, there is plenty of anecdotal evidence claiming it is effective against a host of medical conditions ranging from anxiety to chronic pain and high blood pressure. Now it seems that cannabidiol has another use up its sleeve.

HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (TSX.V: HTC), closed Wednesday's trading session at $0.315, off by 4.5455%, on 103,500 volume with 26 trades. The average volume for the last 3 months is 117,825 and the stock's 52-week low/high is $0.079999998/$1.24.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, continues to progress the development and patenting of its DehydraTECH(TM) platform. An article discussing the company reads, “The DehydraTECH(TM) drug-delivery platform can be used to deliver substances in edible or in beverage form, and in capsules, pills, syrups and more. To view the full article, visit http://cnw.fm/doX61.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Wednesday's trading session at $0.5101, off by 4.6542%, on 131,649 volume with 67 trades. The average volume for the last 3 months is 89,346 and the stock's 52-week low/high is $0.399800002/$1.6875.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America (OTCQB: MCOA) was featured today in a publication from HempWireNews, examining how, according to agriculture officials in Wisconsin, the 2020 planting season will not be affected by the new federal rules on industrial hemp. Last week, the USDA released an interim final rule for establishing the Domestic Hemp Production Program. The USDA was mandated by the 2018 U.S. Farm Bill to develop federal regulations for industrial hemp growth.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Wednesday's trading session at $0.1485, off by 2.9412%, on 121,769 volume with 87 trades. The average volume for the last 3 months is 309,729 and the stock's 52-week low/high is $0.023/$2.10599994.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

The field of drug development for cancer treatment involves costly and time-intensive research. As technology plays an ever-increasing role in driving medicine, researchers and clinicians are discovering the significant potential of patient-derived models in matching specific cancer types with their most effective treatments. These models, which harness the patients’ own cancer cells to best determine how to defeat them, have been shown to be “a valuable tool for the identification of new treatment targets” (http://nnw.fm/BI5pI). To prepare for this next major frontier of precision medicine, industry leaders realize the critical value in these patient-derived (PDx) models of cancer. While most competitors are just getting their feet wet in both developing these PDx models and generating data from them, Predictive Oncology Inc. (NASDAQ: POAI) has been swimming in the deep end for some time, boasting an immensely valuable historic database of drug response for patients from its own proprietary PDx tumor models.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Wednesday's trading session at $3.925, off by 6.4095%, on 21,968 volume with 154 trades. The average volume for the last 3 months is 14,432 and the stock's 52-week low/high is $3.31999993/$8.50.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was featured today in a publication from Financialnewsmedia.com, examining how CBD is quickly becoming a multi-billion-dollar business.  In fact, sales of products containing CBD are expected to grow 700% in 2019 year over year, says the Brightfield Group. 

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Wednesday's trading session at $0.5929, off by 10.1667%, on 729,962 volume with 388 trades. The average volume for the last 3 months is 525,127 and the stock's 52-week low/high is $0.479999989/$1.7888.

Recent News

chart

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)

The QualityStocks Daily Newsletter would like to spotlight Wonderfilm Media Corporation (OTC: WDRFF).

Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF), a publicly traded entertainment company, with offices in Los Angeles and Vancouver, has developed a risk-averse production process that provides forecastable and consistent revenues. This innovative approach assures that Wonderfilm productions are structured to start generating a return to the company as soon as the camera starts rolling.

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.

Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.

Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.

The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.

Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.

Management Team with Proven Track Records

Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.

Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.

Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.

Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.

Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.

17-Title Movie Slate — Greenlit

Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.

Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.

The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.

 

Potential for Breakout Success

Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.

Note: Potential breakout films are not factored into company’s revenue projections.

Base Hits and Home Runs

In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.

Recent Industry Breakout Films Include:

  • SAW – $1.2 million budget = $103.9 million in sales
  • Pulp Fiction – $8 million budget = $212 million in sales
  • My Big Fat Greek Wedding – $5 million budget = $250 million in sales
  • Lost in Translation – $4 million budget = $120 million in sales
  • Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)

Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.

Recent Wonderfilm Releases

  • Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
  • Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
  • Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
  • Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.

Wonderfilm Global Distribution

At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.

Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.

The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.

A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.

Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.

Wonderfilm Business Model

Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.

Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.

Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.

Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.

Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.

Sales overages once contracted presale threshold is surpassed.

The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.

Note: The nature of the film business is that box office revenue lags production up to a couple of years.

$50 Million Wonderfilm Production Fund (WPF):

Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.

The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.

For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.

All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.

Wonderfilm Media Corporation (OTC: WDRFF), closed Wednesday's trading session at $0.1489, off by 0.067114%, on 2,150 volume with 5 trades. The average volume for the last 3 months is 46,588 and the stock's 52-week low/high is $0.075099997/$0.504400014.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.